Profil
Hiroyuki Kojima is Vice President of Clinical Development for Atani Ltd. He has been a Member of ASCO since 1997.
Previously, he was Director of Oncology for Rhone-Poulenc Rorer and Aventis from 1998 to 2004.
Before that, Dr. Kojima worked with Nippon Merck Banyu from 1975 to1981 and held various positions at Bristol-Myers.
He has over 30 years of experience in global pharmaceutical companies.
Dr. Kojima received a PhD degree in Pharmaceutical Faculty from Nagoya City University in 1975.
Anciens postes connus de Hiroyuki Kojima
| Sociétés | Poste | Fin |
|---|---|---|
Atani Ltd.
Atani Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets drugs | Directeur Technique/Scientifique/R&D | 11/07/2013 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Directeur/Membre du Conseil | 01/01/1981 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formation de Hiroyuki Kojima
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
Nagoya University
Nagoya University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atani Ltd.
Atani Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets drugs | Health Technology |
















